stockrowNurix Therapeutics, Inc. (NRIX) vs Precigen, Inc. (PGEN)
- Nurix Therapeutics, Inc. NRIX 15.51 −0.58%
- Precigen, Inc. PGEN 4.54 −2.58%
Nurix Therapeutics, Inc. and Precigen, Inc. are both Biotechnology companies. Nurix Therapeutics, Inc. and Precigen, Inc. are of similar size ($1.7B and $1.7B). Nurix Therapeutics, Inc. trades at the lower P/E: 6.2× against 61.8×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against 738.8%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs 15.6%) and the lower return on invested capital (0.00% vs 15.9%). Across the 20 metrics below, Nurix Therapeutics, Inc. leads on 17 and Precigen, Inc. on 3.
Valuation
Profitability
| Metric | NRIX | PGEN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 91.42% | 67.24% |
| Operating margin | 41.27% | 21.43% | 0.00% |
| Net margin | 42.01% | 15.55% | 0.00% |
| Free cash flow margin | 52.68% | (47.35%) | 0.00% |
| Return on equity | 43.99% | 38.84% | (50.28%) |
| Return on assets | 34.33% | 12.73% | (45.89%) |
| Return on invested capital | 0.00% | 15.93% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack